Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Return on Assets (2020 - 2025)

Historic Return on Assets for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to 0.05%.

  • Apellis Pharmaceuticals' Return on Assets rose 3200.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.24% for FY2024, which is 4500.0% up from last year.
  • Per Apellis Pharmaceuticals' latest filing, its Return on Assets stood at 0.05% for Q3 2025, which was up 3200.0% from 0.28% recorded in Q2 2025.
  • Apellis Pharmaceuticals' 5-year Return on Assets high stood at 0.05% for Q3 2025, and its period low was 1.06% during Q4 2021.
  • Its 5-year average for Return on Assets is 0.54%, with a median of 0.59% in 2022.
  • Per our database at Business Quant, Apellis Pharmaceuticals' Return on Assets tumbled by -7800bps in 2021 and then soared by 4400bps in 2024.
  • Quarter analysis of 5 years shows Apellis Pharmaceuticals' Return on Assets stood at 1.06% in 2021, then rose by 25bps to 0.8% in 2022, then rose by 18bps to 0.66% in 2023, then soared by 66bps to 0.22% in 2024, then skyrocketed by 122bps to 0.05% in 2025.
  • Its Return on Assets was 0.05% in Q3 2025, compared to 0.28% in Q2 2025 and 0.26% in Q1 2025.